Clinical Trials Directory

Trials / Unknown

UnknownNCT02497911

A Trial Comparing Adductor Canal Catheter and Intraarticular Catheter Following Primary Total Knee Arthroplasty

A Randomized Controlled Trial Comparing the Adductor Canal Catheter (ACC) and Intra-articular Catheter (IAC) Following Primary Total Knee Arthroplasty

Status
Unknown
Phase
Phase 4
Study type
Interventional
Enrollment
110 (estimated)
Sponsor
Thomas Jefferson University · Academic / Other
Sex
All
Age
40 Years – 85 Years
Healthy volunteers
Not accepted

Summary

The study is a prospective randomized controlled trial comparing intraarticular catheters and adductor canal catheters for postoperative analgesia following a primary Total Knee Arthroplasty (TKA).

Detailed description

The study is a prospective, randomized controlled clinical trial comparing two methods of postoperative analgesia following primary TKA. Eligible primary TKA patients must be ASA I - III and require less than 20 mg oxycodone daily (or its equivalent). Exclusion criteria are: allergy to anesthetics, contraindication to regional anesthesia, sensory/motor disorder involving operative limb, non-english speaking, ASA IV or greater, psychiatric or cognitive disorders, incarceration, renal insufficiency with Cr \> 2.0 and hepatic failure. When patients agree to participate in the study the following data will be collected by the research staff: ASA physical status, age, height, weight, gender, quantitative opiate use, numeric pain score with visual descriptors, painDETECT score (form included), WOMAC score (form included) and baseline Pain Management Questionnaire. When designated through randomization, intra-articular catheters will be placed intraoperatively by the surgeons, per usual protocol. ACC's will be placed postoperatively in the PACU. The catheters will exit the bandage in a similar fashion to blind the personnel collecting data, postoperatively. Those collecting data will not be blinded from identifying patients in the control group, as no catheter will exit the bandage. Potential risks for each procedure, which will be explained to the patient, include: bleeding, local infection, local anesthetic toxicity in the form of seizure and cardiac arrest and neuropathy. The preceding are commonly listed though infrequent complications of both procedures. Continuous ultrasound will guide the placement of the ACC.

Conditions

Interventions

TypeNameDescription
PROCEDUREAdductor Canal Catheter0.5% Ropivicaine for primary block and 0.2% Ropivicaine infusion by OnQ Pump
PROCEDUREIntraarticular Catheter0.5% Bupivicaine for primary block and 0.125% Bupivicaine infusion by OnQ Pump
DRUGRopivicaine
DRUGBupivicaine

Timeline

Start date
2014-01-01
Primary completion
2015-11-01
Completion
2015-11-01
First posted
2015-07-15
Last updated
2015-10-23

Source: ClinicalTrials.gov record NCT02497911. Inclusion in this directory is not an endorsement.